Mike Doustdar
Pharma

Novo CEO talks embracing change and staying bullish amid rebrand

CEO Mike Doustdar told Fierce that there was a recognition, both internally and externally, that Novo needed to make some changes to its business.
Fraiser Kansteiner Sep 17, 2026 8:45am
FDA

New FDA oncology chief sets priorities in first interview

Sep 11, 2026 4:00am
Advancing Treatment A Closer Look at ADT Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
Sunrise over foggy forest in Tuscany Italy

FDA approves Ultragenyx gene therapy after prior rejection

Sep 17, 2026 4:50pm
How is API Manufacturing Changing

How is API Manufacturing Changing?

Brought to you by WuXi AppTec
FDA approved stamp regulations yes go

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Sep 17, 2026 2:06pm
More News

Roche reports positive confirmatory trial readout for Lunsumio

Sep 17, 2026 11:25am

Bavarian Nordic taps Sanofi vet to replace outgoing CEO Chaplin

Sep 17, 2026 11:16am

Lilly boxes up fresh produce to cultivate Alzheimer’s awareness

Sep 17, 2026 10:13am

Comedian Damon Wayans on humor, relatability and DME awareness

Sep 17, 2026 9:34am